On Aug. 2, the AANS and the CNS submitted comments to Reps. Larry Bucshon, MD, (R-Ind.) and Diana DeGette (D-Colo.) on the progress of and future directions for the CURES 2.0 Act. The 21st Century Cures Act has successfully advanced multiple initiatives addressing neurological diseases and disorders, but there is still much to be done to produce transformative solutions for patients. The comment letter expresses support for the use of registry data and approval of and reimbursement for innovative treatment.
Click here to read the comment letter.
